Matrix and Cell Technologies

Matrix Technologies and Cell Engineering

Investigating cardiac regeneration using iPSC-derived cardiac organoids. Utilizing gene-editing approaches to engineer iPSCs as fundamental building blocks for tissue engineering purposes. Functionalization and optimization of human tissue engineered matrices.

Pic1_MM
Graphical abstract to depict the overarching theme of Matrix and Cell Technologies. Utilizing iPSC-biology and gene-editing approaches, such as CRISPR-Cas9, to customize and optimize our current human tissue engineered matrices and cardiac organoids for enhanced clinical applications.